Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2022 Volume 26 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 26 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Novel splice‑site variants c.393G>A, c.278_2A>G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder

  • Authors:
    • Kuyaş Heki̇mler Öztürk
    • Güli̇n Özdamar Ünal
  • View Affiliations / Copyright

    Affiliations: Department of Medical Genetics, Faculty of Medicine, Süleyman Demirel University, Isparta 32260, Turkey, Department of Psychiatry, Faculty of Medicine, Süleyman Demirel University, Isparta 32260, Turkey
    Copyright: © Öztürk et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 293
    |
    Published online on: August 2, 2022
       https://doi.org/10.3892/mmr.2022.12810
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

NOD‑like receptor pyrin domain‑containing 3 (NLRP3) has been considered to play a crucial role in triggering the host's immune and inflammatory responses. Genetic variants are critical determinants of interindividual variances in inflammatory responses and clinical outcomes. The role of NLRP3 gene variations in bipolar I (BPI) disorder, which is known to include genetic factors in its aetiology, has not been previously reported, at least to the best of our knowledge. The present study aimed to determine the role and frequency ofta exon 2 and exon 3 variants of NLRP3 in BPI disorder and to evaluate the association between different phenotypic traits. A case‑control study with 123 patients and 107 healthy controls was conducted to investigate the association of variants identified in the exon 2 and exon 3 regions of NLRP3, with the risk of BPI. Regions of interest were sequenced using a PCR‑based Sanger sequencing method. Three BPI‑related variants were identified. The genotype Q705K CA was detected more frequently in BPI patients, as compared to the control group [P<0.001; odds ratio (OR), 0.202; 95% confidence interval (CI), 0.080‑0.508]. In addition, two novel splice‑site variants (c.393G>A and c.278_2A>G) that, to the best of our knowledge, have not been previously reported in any database, were detected only in the BPI patient group [P<0.001; OR, 0.846; 95% CI, 0.784‑0.912; P<0.001; OR, 0.886; 95% CI, 0.832‑0.944, respectively]. There was no significant association between the Q795K variant and phenotypic traits (P>0.05). However, there was a significant association between those carrying the heterozygous c.393G>A variant and a positive family history (P=0.043). It was also observed that those with the heterozygous c.278‑2A>G variant presented with a significantly early‑onset (P=0.003). On the whole, the data of the present study suggested that NLRP3 plays a crucial role in the pathogenesis of BPI and may be a potential risk factor. However, further functional studies and repeated studies in other populations are required to properly comprehend the roles of the NLRP3 variants in the risk of developing BPI.
View Figures

Figure 1

View References

1 

Pereira AC, Oliveira J, Silva S, Madeira N, Pereira CM and Cruz MT: Inflammation in bipolar disorder (BD): Identification of new therapeutic targets. Pharmacol Res. 163:1053252021. View Article : Google Scholar : PubMed/NCBI

2 

Gubert C, Andrejew R, Moritz CE, Dietrich F, Vasconcelos-Moreno MP, Dos Santos BT, Fijtman A, Kauer-Sant'Anna M, Kapczinski F, da Silva Magalhães PV and Battastini AM: Bipolar disorder and 1513A>C P2RX7 polymorphism frequency. Neurosci Lett. 16:143–147. 2019. View Article : Google Scholar

3 

Prata DP, Costa-Neves B, Cosme G and Vassos E: Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. J Psychiatr Res. 114:178–207. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Gordovez FJ and McMahon FJ: The genetics of bipolar disorder. Mol Psychiatry. 25:544–559. 2020. View Article : Google Scholar : PubMed/NCBI

5 

Gunderson JG, Zanarini MC, Choi-Kain LW, Mitchell KS, Jang KL and Hudson JI: Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry. 68:753–762. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, Carvalho AF, Ashton MM, Berk L, Cotton SM, et al: Staging in bipolar disorder: From theoretical framework to clinical utility. World Psychiatry. 16:236–244. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Sigitova E, Fišar Z, Hroudová J, Cikánková T and Raboch J: Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci. 71:77–103. 2017. View Article : Google Scholar

8 

Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD and Latz E: Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 17:6882018. View Article : Google Scholar : PubMed/NCBI

9 

Zhang AQ, Zeng L, Gu W, Zhang LY, Zhou J, Jiang DP, Du DY, Hu P, Yang C, Yan J, et al: Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma. Crit Care. 15:R2802011. View Article : Google Scholar : PubMed/NCBI

10 

Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, Baba N, Libioulle C, Belaiche J, Bitton A, et al: Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet. 41:71–76. 2009. View Article : Google Scholar

11 

Wu Z, Wu S and Liang T: Association of NLRP3 rs35829419 and rs10754558 polymorphisms with risks of autoimmune diseases: A systematic review and meta-analysis. Front Genet. 12:6908602021. View Article : Google Scholar

12 

Verma D, Lerm M, Julinder RB, Eriksson P, Söderkvist P and Särndahl E: Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: Relation to common inflammatory diseases? Arthritis Rheum. 58:888–894. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Kastbom A, Johansson M, Verma D, Söderkvist P and Rantapää-Dahlqvist S: CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis. Ann Rheum Dis. 69:723–726. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Juneblad K, Kastbom A, Johansson L, Rantapää-Dahlqvist S, Söderkvist P and Alenius GM: Association between inflammasome-related polymorphisms and psoriatic arthritis. Scand J Rheumatol. 50:206–212. 2021. View Article : Google Scholar

15 

Pontillo A, Brandao L, Guimaraes R, Segat L, Araujo J and Crovella S: Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity. 43:583–589. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Imani D, Azimi A, Salehi Z, Rezaei N, Emamnejad R, Sadr M and Izad M: Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis. Int J Immunogenet. 45:329–336. 2018. View Article : Google Scholar

17 

Xu L, Li S, Liu Z, Jiang S, Wang J, Guo M, Zhao X, Song W and Liu S: The NLRP3 rs10754558 polymorphism is a risk factor for preeclampsia in a Chinese Han population. J Matern Neonatal Med. 32:1792–1799. 2019. View Article : Google Scholar

18 

Zhou XY, Fernando SM, Pan AY, Laposa R, Cullen KR, Klimes-Dougan B and Andreazza AC: Characterizing the NLRP3 inflammasome in mood disorders: Overview, technical development, and measures of peripheral activation in adolescent patients. Int J Mol Sci. 22:125132021. View Article : Google Scholar

19 

Özerdem A, Yazıcı O, Tunca Z and Tırpan K: Establishment of computerized registry program for bipolar illnes in turkey: SKIP-TURK. J Affect Disord. 84:82–86. 2004.

20 

First MB, Williams JB, Karg RS and Spitzer RL: User's guide for the SCID-5-CV Structured Clinical Interview for DSM-5® disorders: Clinical version: American Psychiatric Publishing, Inc. 2016.

21 

Elbir M, Topbaş ÖA, Bayad S, Kocabaş T, Topak OZ, Çetin Ş, Özdel O, Ateşçi F and Aydemir Ö: Adaptation and reliability of the structured clinical interview for DSM-5-disorders-clinician version (SCID-5/CV) to the Turkish language. Turk Psikiyatri Derg. 30:51–56. 2019.(In Turkish). PubMed/NCBI

22 

Young RC, Biggs JT, Ziegler VE and Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry. 133:429–435. 1978. View Article : Google Scholar : PubMed/NCBI

23 

Karadag F, Oral T, Yalcin FA and Erten E: Reliability and validity of Turkish translation of young mania rating scale. Turk Psikiyatri Derg. 13:107–114. 2002.(In Turkish). PubMed/NCBI

24 

Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62. 1960. View Article : Google Scholar : PubMed/NCBI

25 

Akdemir A, Türkçapar MH, Örsel SD, Demirergi N, Dag I and Özbay MH: Reliability and validity of the Turkish version of the hamilton depression rating scale. Compr Psychiatry. 42:161–165. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, et al: Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 3:52007. View Article : Google Scholar : PubMed/NCBI

27 

Aydemir O and Uykur B: Reliability and validity study of the Turkish version of functioning assessment short test in bipolar disorder. Turk Psikiyatri Derg. 23:193–200. 2012.(In Turkish). PubMed/NCBI

28 

Hamshere ML, Gordon-Smith K, Forty L, Jones L, Caesar S, Fraser C, Hyde S, Tredget J, Kirov G, Jones I, et al: Age-at-onset in bipolar-I disorder: Mixture analysis of 1369 cases identifies three distinct clinical sub-groups. J Affect Disord. 116:23–29. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Grigoroiu-Serbanescu M, Martinez M, Nöthen MM, Grinberg M, Sima D, Propping P, Marinescu E and Hrestic M: Different familial transmission patterns in bipolar I disorder with onset before and after age 25. Am J Med Genet. 105:765–773. 2001. View Article : Google Scholar

30 

Namipashaki A, Razaghi-Moghadam Z and Ansari-Pour N: The essentiality of reporting hardy-weinberg equilibrium calculations in population-based genetic association studies. Cell J. 17:187–192. 2015.PubMed/NCBI

31 

Bryant C and Fitzgerald KA: Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19:455–464. 2009. View Article : Google Scholar

32 

Zhou R, Yazdi AS, Menu P and Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature. 469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Wei P, Yang F, Zheng Q, Tang W and Li J: The potential role of the NLRP3 inflammasome activation as a link between mitochondria ROS generation and neuroinflammation in postoperative cognitive dysfunction. Front Cell Neurosci. 13:732019. View Article : Google Scholar

34 

Zhang Q, Fan HW, Zhang JZ, Wang YM and Xing HJ: NLRP3 rs35829419 polymorphism is associated with increased susceptibility to multiple diseases in humans. Genet Mol Res. 14:13968–13980. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Pontillo A, Vendramin A, Catamo E, Fabris A and Crovella S: The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am J Gastroenterol. 106:539–544. 2011. View Article : Google Scholar

36 

Roberts RL, Topless RKG, Phipps-Green AJ, Gearry RB, Barclay ML and Merriman TR: Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun. 11:351–356. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Agah E, Nafissi S, Saleh F, Sarraf P, Tafakhori A, Mousavi SV, Saghazadeh A, Sadr M, Sinaei F, Mohebbi B, et al: Investigating the possible association between NLRP3 gene polymorphisms and myasthenia gravis. Muscle Nerve. 63:730–736. 2021. View Article : Google Scholar : PubMed/NCBI

38 

Pontillo A, Girardelli M, Kamada AJ, Pancotto JAT, Donadi EA, Crovella S and Sandrin-Garcia P: Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity. 45:271–278. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Redenšek S, Flisar D, Kojović M, Kramberger MG, Georgiev D, Pirtošek Z, Trošt M and Dolžan V: Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease. J Neuroinflammation. 16:502019. View Article : Google Scholar

40 

Hanaei S, Sadr M, Rezaei A, Shahkarami S, Daryani NE, Bidoki AZ and Rezaei N: Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study. Clin Res Hepatol Gastroenterol. 42:269–275. 2018. View Article : Google Scholar

41 

Herman R, Jensterle M, Janež A, Goričar K and Dolžan V: Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome. Metabolites. 10:4392020. View Article : Google Scholar

42 

Antypa N and Serretti A: Family history of a mood disorder indicates a more severe bipolar disorder. J Affect Disord. 156:178–186. 2014. View Article : Google Scholar : PubMed/NCBI

43 

Zalar B, Blatnik A, Maver A, Klemenc-Ketiš Z and Peterlin B: Family history as an important factor for stratifying participants in genetic studies of major depression. Balkan J Med Genet. 21:5–12. 2018. View Article : Google Scholar

44 

Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE Jr, Leverich GS and Nolen WA: Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder. Bipolar Disord. 21:doi: 10.1111/bdi.12668. 2018.(Epub ahead of print). PubMed/NCBI

45 

Axelson D, Goldstein B, Goldstein T, Monk K, Yu H, Hickey MB, Sakolsky D, Diler R, Hafeman D, Merranko J, et al: Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: A longitudinal study. Am J Psychiatry. 172:638–646. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Studart-Bottó P, Bezerra-Filho S, Sarmento S and Miranda-Scippa Â: Social support in patients with bipolar disorder and differing ages at onset. Clin Psychol Psychother. 29:351–359. 2022. View Article : Google Scholar

47 

Geoffroy PA, Etain B, Scott J, Henry C, Jamain S, Leboyer M and Bellivier F: Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset. J Physiol. 107:278–285. 2013.

48 

Grigoroiu-Serbanescu M, Rietschel M, Hauser J, Czerski PM, Herms S, Sun X, Wickramaratne P and Elston RC: Commingling analysis of age-of-onset in bipolar I disorder and the morbid risk for major psychoses in first degree relatives of bipolar I probands. J Affect Disord. 168:197–204. 2014. View Article : Google Scholar : PubMed/NCBI

49 

Kennedy KP, Cullen KR, Deyoung CG and Klimes-Dougan B: The genetics of early-onset bipolar disorder: A systematic review. J Affect Disord. 184:1–12. 2015. View Article : Google Scholar : PubMed/NCBI

50 

Soni A, Singh P, Kumar S, Shah R, Batra L and Verma M: Role of age at onset in the clinical presentation of bipolar disorder in Indian population. Ind Psychiatry J. 30:41–46. 2021. View Article : Google Scholar : PubMed/NCBI

51 

Wu LS, Huang MC, Fann CS, Lane HY, Kuo CJ, Chiu WC, Kwok PY and Cheng AT: Genome-wide association study of early-onset bipolar I disorder in the Han Taiwanese population. Transl Psychiatry. 11:3012021. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Öztürk KH and Ünal GÖ: Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder. Mol Med Rep 26: 293, 2022.
APA
Öztürk, K.H., & Ünal, G.Ö. (2022). Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder. Molecular Medicine Reports, 26, 293. https://doi.org/10.3892/mmr.2022.12810
MLA
Öztürk, K. H., Ünal, G. Ö."Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder". Molecular Medicine Reports 26.3 (2022): 293.
Chicago
Öztürk, K. H., Ünal, G. Ö."Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder". Molecular Medicine Reports 26, no. 3 (2022): 293. https://doi.org/10.3892/mmr.2022.12810
Copy and paste a formatted citation
x
Spandidos Publications style
Öztürk KH and Ünal GÖ: Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder. Mol Med Rep 26: 293, 2022.
APA
Öztürk, K.H., & Ünal, G.Ö. (2022). Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder. Molecular Medicine Reports, 26, 293. https://doi.org/10.3892/mmr.2022.12810
MLA
Öztürk, K. H., Ünal, G. Ö."Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder". Molecular Medicine Reports 26.3 (2022): 293.
Chicago
Öztürk, K. H., Ünal, G. Ö."Novel splice‑site variants c.393G&gt;A, c.278_2A&gt;G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder". Molecular Medicine Reports 26, no. 3 (2022): 293. https://doi.org/10.3892/mmr.2022.12810
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team